CNM Publications 2009 to Present

Selected Publications

Found 116 results
Author Title Type [ Year(Desc)]
Park J-H, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ.  2009.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications.. Nat Mater. 8(4):331-6.
Fogal V, Sugahara KN, Ruoslahti E, Christian S.  2009.  Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.. Angiogenesis. 12(1):91-100.
Teesalu T, Sugahara KN, Kotamraju VRamana, Ruoslahti E.  2009.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.. Proc Natl Acad Sci U S A. 106(38):16157-62.
Simberg D, Zhang W-M, Merkulov S, McCrae K, Park J-H, Sailor MJ, Ruoslahti E.  2009.  Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.. J Control Release. 140(3):301-5.
Wang H, Zhang W, Tang R, Hebbel RP, M Kowalska A, Zhang C, Marth JD, Fukuda M, Zhu C, Huo Y.  2009.  Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.. Arterioscler Thromb Vasc Biol. 29(7):1053-9.
Wang H, Tang R, Zhang W, Amirikian K, Geng Z, Geng J, Hebbel RP, Xia L, Marth JD, Fukuda M et al..  2009.  Core2 1-6-N-glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice.. Arterioscler Thromb Vasc Biol. 29(2):180-7.
Simberg D, Park J-H, Karmali PP, Zhang W-M, Merkulov S, McCrae K, Bhatia SN, Sailor M, Ruoslahti E.  2009.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.. Biomaterials. 30(23-24):3926-33.
Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sørensen ALouise, Larson G, Marth JD, Hartwig JH, Hoffmeister KM.  2009.  Dual roles for hepatic lectin receptors in the clearance of chilled platelets.. Nat Med. 15(11):1273-80.
Kastantin M, Ananthanarayanan B, Karmali P, Ruoslahti E, Tirrell M.  2009.  Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles.. Langmuir. 25(13):7279-86.
Stone EL, Ismail MNazri, Lee SHo, Luu Y, Ramirez K, Haslam SM, Ho SB, Dell A, Fukuda M, Marth JD.  2009.  Glycosyltransferase function in core 2-type protein O glycosylation.. Mol Cell Biol. 29(13):3770-82.
Zanuy D, Flores-Ortega A, Jiménez AI, M Calaza I, Cativiela C, Nussinov R, Ruoslahti E, Alemán C.  2009.  In silico molecular engineering for a targeted replacement in a tumor-homing peptide.. J Phys Chem B. 113(22):7879-89.
Montpetit ML, Stocker PJ, Schwetz TA, Harper JM, Norring SA, Schaffer L, North SJ, Jang-Lee J, Gilmartin T, Head SR et al..  2009.  Regulated and aberrant glycosylation modulate cardiac electrical signaling.. Proc Natl Acad Sci U S A. 106(38):16517-22.
Zhang Y, Yang M, Park J-H, Singelyn J, Ma H, Sailor MJ, Ruoslahti E, Ozkan M, Ozkan C.  2009.  A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles.. Small. 5(17):1990-6.
Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Marth JD, Bertozzi CR, Hart GW, Etzler ME.  2009.  Symbol nomenclature for glycan representation.. Proteomics. 9(24):5398-9.
Park J-H, von Maltzahn G, Zhang L, Derfus AM, Simberg D, Harris TJ, Ruoslahti E, Bhatia SN, Sailor MJ.  2009.  Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting.. Small. 5(6):694-700.
Peters D, Kastantin M, Kotamraju VRamana, Karmali PP, Gujraty K, Tirrell M, Ruoslahti E.  2009.  Targeting atherosclerosis by using modular, multifunctional micelles.. Proc Natl Acad Sci U S A. 106(24):9815-9.
Karmali PPrakash, Kotamraju VRamana, Kastantin M, Black M, Missirlis D, Tirrell M, Ruoslahti E.  2009.  Targeting of albumin-embedded paclitaxel nanoparticles to tumors.. Nanomedicine. 5(1):73-82.
Sugahara KN, Teesalu T, Karmali PPrakash, Kotamraju VRamana, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E.  2009.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.. Cancer Cell. 16(6):510-20.
Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N.  2010.  Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.. J Biol Chem. 285(9):6515-21.
Sugahara KN, Teesalu T, Karmali PPrakash, Kotamraju VRamana, Agemy L, Greenwald DR, Ruoslahti E.  2010.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.. Science. 328(5981):1031-5.
Park J-H, von Maltzahn G, Xu MJue, Fogal V, Kotamraju VRamana, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanomaterial system to sensitize, target, and treat tumors.. Proc Natl Acad Sci U S A. 107(3):981-6.
Park J-H, von Maltzahn G, Ong LL, Centrone A, T Hatton A, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.. Adv Mater. 22(8):880-5.
Lee SHo, Yu S-Y, Nakayama J, Khoo K-H, Stone EL, Fukuda MN, Marth JD, Fukuda M.  2010.  Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.. J Biol Chem. 285(48):37683-92.
Gu L, Park J-H, Duong KH, Ruoslahti E, Sailor MJ.  2010.  Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads.. Small. 6(22):2546-52.
Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E.  2010.  Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.. Mol Cell Biol. 30(6):1303-18.